Evidence-Based Hormone Optimization for Your Health

Evidence-Based Hormone Optimization and Integrative Chiropractic Care: Practical Protocols, Physiology, and Patient-Centered Strategies

Abstract

In this educational post, I walk you through a practical, evidence-based roadmap for optimizing hormone health across scenarios I routinely encounter in clinic: iron deficiency and heavy menstrual bleeding, PCOS management, post–gastric bypass care, male hormone therapy and estrogen balance, dosing and pharmacokinetics of testosterone pellets, contraceptive decision-making and thrombotic risk, SHBG-related nonresponse, and progesterone selection across the reproductive lifespan. I also integrate modern, physiologically grounded approaches with chiropractic and functional medicine frameworks to support vascular, autonomic, and musculoskeletal systems that influence endocrine function. Drawing on leading research and my clinical observations, I explain the “why” behind protocols, how integrative chiropractic care fits into treatment, and the methods I use to personalize therapy for durable outcomes.

Introduction: Building the Right Care Team and Strategy

I have learned that effective hormone care starts by getting the right people in the room. Complex hormone cases often involve overlapping issues—iron deficiency, thyroid function, metabolic status, contraceptive needs, renal clearance, and gut absorption—and they improve most when we combine the strengths of primary care, endocrinology, gynecology, men’s health, nutrition, behavioral health, and integrative chiropractic care. My role is to coordinate these inputs, apply modern, evidence-based methods, and ensure the physiology guides the protocol.

My care plans emphasize:

• Thorough assessment of iron, thyroid, and sex steroids
• Understanding pharmacokinetics (absorption, distribution, excretion)
• Addressing gut and hepatic factors (especially post–gastric bypass)
• Matching progesterone and progestin choices to goals (birth control vs symptom relief)
• Considering SHBG dynamics when patients fail to respond
• Using integrative chiropractic care to optimize autonomic tone, circulation, sleep, pain, and exercise capacity

Below, I present key conceptual areas, each with the physiology, protocols, and clinical pearls that help patients consistently achieve better outcomes.

Optimizing Iron, Copper, and Thyroid for Women with Heavy Bleeding

When women present with heavy menstrual bleeding, I start by acknowledging the common but often underrecognized iron deficiency, sometimes without overt anemia. Chronic blood loss depletes iron stores (low ferritin), lowering hemoglobin synthesis and oxygen delivery to tissues. Low iron can amplify fatigue, hair loss, palpitations, and cognitive fog. Iron also interplays with copper and thyroid function—copper supports iron mobilization via ceruloplasmin, while thyroid hormones increase erythropoiesis and basal metabolic rate.

Why I use these strategies:

• Iron repletion: Restores hemoglobin, reduces fatigue, improves exercise tolerance; ferritin targets are individualized, but I often aim for >50–75 ng/mL in symptomatic patients with ongoing menstrual losses.
• Copper sufficiency: Prevents functional iron deficit due to impaired iron transport; I consider copper status if ferritin fails to rise with iron therapy.
• Thyroid normalization: Hypothyroidism can worsen menorrhagia by altering clotting and endometrial turnover and impairing erythropoiesis; optimizing TSH, FT4, and FT3 improves menstrual regularity and energy levels.

Cyclic progesterone can meaningfully reduce bleeding in appropriate patients by stabilizing the endometrium. In practice:

• I trial cyclic micronized progesterone during luteal phases to reduce heavy bleeding and to support sleep via GABAergic effects.
• I layer iron supplementation and thyroid protocols when labs support it, ensuring gut-friendly iron formulations or IV iron if absorption is compromised.

Integrative chiropractic care fits here by:

• Addressing thoracic and cervical autonomic balance to improve vascular tone and heart rate variability, which helps fatigue and sleep quality.
• Improving ribcage mechanics and diaphragmatic function to enhance oxygenation and reduce perceived exertional fatigue.
• Coaching graded exercise and recovery to leverage improved oxygen delivery post-iron repletion.

PCOS: Protocols and Practical Dosing Considerations

In PCOS, I focus on insulin resistance, hyperandrogenism, ovulatory dysfunction, and immune-metabolic contributors. If we discuss a “60%” dosing concept, it typically refers to selecting conservative initial doses for hormonal therapies to prevent overshooting and to titrate toward symptom and lab targets.

In practice:

• A diet that improves insulin sensitivity (low-glycemic-load, nutrient-dense) can reduce ovarian androgen production.
• Inositols, berberine, and sometimes metformin improve insulin signaling and ovulation.
• Cyclic progesterone may help regulate bleeding and reduce the risk of endometrial hyperplasia.
• When profound bleeding occurs, higher initial progesterone dosing cycles may be necessary for stabilization, followed by tapering.

Physiology rationale:

• Insulin and LH signaling at the ovary drive androgen synthesis; lowering insulin reduces theca cell androgen output.
• Progesterone normalizes endometrial proliferation and reduces excessive bleeding.

Integrative chiropractic care supports PCOS by:

• Improving sleep quality, which stabilizes insulin sensitivity and cortisol rhythms.
• Reducing pain and inflammation, facilitating regular exercise, which improves adipokine profiles and insulin signaling.

Post–Gastric Bypass: Absorption, Microbiome, and Hormone Care

After gastric bypass, nutrient absorption changes, including iron, B12, folate, fat-soluble vitamins, and sometimes thyroid medication bioavailability. Hormone-related symptoms may persist or change with rapid weight loss.

My approach:

• Use targeted probiotics to support microbiome diversity and short-chain fatty acid production, aiding gut barrier integrity and nutrient handling.
• Assess for fat-soluble vitamin deficiencies (A, D, E, K) and iron absorption limits; consider IV iron if oral forms fail.
• Tailor hormone dosing with awareness of altered absorption surfaces and accelerated weight-loss distribution changes.

Physiology:

• Bypass alters gastric acid and intestinal transit, reducing mineral ionization and uptake.
• The microbiota influence estrogen deconjugation (estrogen enterohepatic cycling) and systemic inflammation, thereby affecting hormone sensitivity.

Chiropractic integration:

• Thoracolumbar adjustments may improve autonomic balance and gut motility via modulation of the enteric nervous system.
• Exercise prescriptions emphasize core stability, low-impact conditioning, and gradual progress as weight declines.

Managing Male Estrogen Symptoms During Testosterone Therapy

Men occasionally report breast tenderness or heightened sensitivity early in testosterone therapy due to transient rises in estradiol via aromatization. My experience is that this generally occurs at the start, during the transition from low to therapeutic androgen levels.

Strategy:

• Educate that early sensitivity is common and often temporary.
• Consider nutraceutical aromatase modulation, such as DIM (diindolylmethane), when appropriate, if symptoms persist, while avoiding over-suppression of estradiol (which is needed for vascular and bone health).
• Emphasize correct dosing to avoid peaks that drive excess aromatization.

Physiology:

• Testosterone is converted to estradiol via aromatase, which is more abundant in adipose tissue; rapid increases can transiently elevate estradiol before equilibrium is established.
• Balanced estradiol supports endothelial function, libido, and bone remodeling, so the goal is moderation rather than elimination.

Clinical pearl:

• Patients who request extra testosterone sessions due to peer advice often risk soft erections and unstable mood from supraphysiologic dosing without evidence-based indications. I keep dosing aligned with biomarkers and symptom tracking to protect outcomes and safety.

Testosterone Pellets: Absorption, Distribution, and Renal Excretion

Pellet therapy hinges on three pillars: absorption, distribution, and excretion.

• Absorption: Pellets sit in subcutaneous tissue surrounded by capillaries; cardiac output and local perfusion influence the rate. Patients who exercise consistently often achieve more stable levels earlier due to better microcirculation.
• Distribution: Testosterone disperses across body compartments. After significant fat loss, the distribution volume falls, often increasing effective concentrations at the same nominal dose. Therefore, dosing must be revisited post-weight loss to avoid overshooting.
• Excretion: Testosterone metabolites are eliminated predominantly via renal excretion. In older patients or those with sluggish renal clearance, pellets can last longer, so we often reduce the dose to avoid prolonged supratherapeutic levels.

Practical guidance:

• After notable weight loss (for example, dropping from 250 to 190 pounds), I reassess dosage because decreased distribution volume can increase hormone exposure.
• In octogenarians, I commonly use lower doses with longer intervals; some patients experience therapeutic levels for 6–9 months due to slower clearance.

Chiropractic integration:

• Emphasis on circulatory optimization through postural correction, thoracic mobility, and diaphragmatic breathing can improve tissue perfusion and subjective energy during pellet adaptation.
• Strength programs focus on lean mass accrual while safeguarding joints and tendon health.

Contraception, SHBG, DVT Risk, and Hormone Symptom Care

Contraception choices are a risk-benefit calculus. In young women, combined oral contraceptives increase DVT risk modestly; this risk evolves with age and comorbidities. In women around age 45 who do not need pregnancy prevention (IUD in place or tubal ligation), I avoid estrogen-containing birth control for symptom management because safer alternatives exist.

Core protocol:

• If contraception is needed, prefer long-acting progestin IUDs that avoid systemic estrogen, which can elevate SHBG (sex hormone-binding globulin) and further lower free testosterone.
• When women have high SHBG (for example, 100–115 nmol/L), they may feel little benefit from modest testosterone dosing because free fractions are minimal. Without altering the SHBG environment, increasing total testosterone alone may not sufficiently restore free levels.

Physiology:

• Estrogens and thyroid hormones raise SHBG, which binds more testosterone and reduces bioavailable free T.
• Progestin IUDs exert local endometrial effects with minimal systemic SHBG impact, reducing bleeding and pain while preserving androgen availability.

Clinical observation:

• Women with high SHBG are “difficult to make happy” if systemic estrogen therapy continues to raise SHBG. Switching to non-estrogenic contraception can release free testosterone, improving energy, libido, and mood without raising thrombotic risk.

Progesterone vs Progestins: Premenopause, Perimenopause, and Menopause

I differentiate between progesterone (bioidentical, micronized) and progestins (synthetic). The goal matters:

• Birth control often relies on progestins for reliable ovulation suppression.
• Symptom relief (sleep, mood, vasomotor stability, endometrial protection in estrogen therapy) favors micronized progesterone due to more physiologic receptor activity and a beneficial GABAergic profile.

Why this matters:

• Micronized progesterone can improve sleep quality, reduce vasomotor symptoms, and support endometrial safety when estrogen is used for menopausal symptoms.
• Progestins differ in receptor binding, metabolic effects, and vascular profiles; individualized selection reduces adverse effects.

Clinical sequence I use:

• In premenopausal heavy bleeding: cyclic micronized progesterone or an appropriate IUD, combined with iron and thyroid support.
• In perimenopause: cycle-aware progesterone to stabilize mood and sleep, reserving progestins when contraception is needed.
• In menopause: micronized progesterone as part of menopausal hormone therapy when indicated, aligned with breast safety evidence and personalized risk assessment.

Environmental Factors, SHBG Supplements, and Realistic Expectations

Patients often ask about environmental exposures or supplements promising to lower SHBG. While endocrine-disrupting chemicals can affect hormone signaling, clinically significant reductions in SHBG from supplements are often modest (10–15%) and rarely transform outcomes without addressing larger drivers such as estrogen therapy, thyroid status, insulin resistance, and nutrition.

My stance:

• I focus on root causes—reducing exposures, correcting insulin resistance, normalizing thyroid function, optimizing protein intake, and addressing liver health—rather than chasing small SHBG shifts from single supplements.
• I track outcomes with free testosterone, estradiol, DHEA-S, thyroid panel, and ferritin, adjusting therapy based on objective and subjective responses.

Erectile Dysfunction, Arrhythmias, and Testosterone Safety

I occasionally hear concerns that testosterone affects atrial arrhythmias or causes ED via hemoglobin or hematocrit changes. The literature suggests that normalizing testosterone in androgen-deficient men improves vascular function and may enhance the success rates of cardiac rhythm interventions when treated appropriately. ED is more often a vascular or neurogenic issue than directly caused by therapeutic testosterone. I monitor hematocrit and hemoglobin, keep targets within safe limits, and emphasize dose discipline.

Key points:

• Therapeutic testosterone aims for physiologic levels, not supraphysiologic peaks.
• Hematocrit monitoring prevents erythrocytosis; hydration, dose adjustments, and periodic phlebotomy, if necessary, keep levels within range.
• Address comorbidities (sleep apnea, insulin resistance, dyslipidemia) to improve sexual function holistically.

Patient Engagement, Tracking, and Safety Culture

I invite patients to become collaborators. Education and regular check-ins build safety and adherence:

• Baseline and follow-up labs: CBC, CMP, lipid panel, thyroid, ferritin, vitamin D, sex steroids, SHBG.
• Symptom diaries for mood, sleep, libido, bleeding patterns, energy, and exercise tolerance.
• Guardrails: no “extra sessions” outside plan, dose changes only after reassessment, and transparent discussion of risks/benefits.

Integrative Chiropractic Care: The Missing Link That Makes Protocols Work

Chiropractic care is essential in my integrative model because endocrine outcomes depend on autonomic tone, inflammation, and musculoskeletal capacity. Here is how I integrate it:

• Autonomic regulation
  • Goal: Improve parasympathetic activity and reduce sympathetic overdrive to support hormone receptor sensitivity, sleep, and vascular function.
  • Methods: Cervical and thoracic adjustments, breathing coaching, vagal maneuvers, soft-tissue release around the scalene and thoracic inlet to aid perfusion.
• Circulatory and oxygenation support
  • Goal: Enhance capillary perfusion and diaphragmatic mechanics to reduce fatigue and improve outcomes of iron therapy.
  • Methods: Ribcage mobilization, postural corrections, and graded aerobic prescriptions tailored to iron status and renal clearance factors.
• Inflammation and pain modulation
  • Goal: Reduce nociceptive load that perturbs the HPA axis and insulin sensitivity.
  • Methods: Regional joint adjustments, myofascial therapy, anti-inflammatory nutrition coaching, and sleep hygiene interventions.
• Exercise programming for hormone health
  • Goal: Safely increase lean body mass and mitochondrial capacity.
  • Methods: Progressive resistance training, tendon-safe eccentric loading, recovery monitoring (HRV), and workload titration aligned with pellet dosing phases and iron status.

Clinical Observations from My Practice

From my work with injury recovery and functional medicine patients, several observations stand out:

• Patients with high SHBG on estrogenic contraception rarely feel androgen benefits until contraception is changed; switching to progestin IUDs often unlocks free T gains and symptom relief.
• Post–gastric bypass patients do better when we pair micronutrient repletion (iron, B12, D) with microbiome support and core-stability exercise, improving absorption signals and energy.
• In men, early estradiol-related tenderness subsides with dose discipline and improvements in body composition; chronic cases respond to targeted aromatase modulation and lifestyle changes rather than to blunt estrogen blockade.
• In heavy bleeding, combining cyclic progesterone, iron, and thyroid normalization yields durable symptom control and better exercise adherence, which further stabilizes hormones.

Patient Safety Notes and Practical Takeaways

• Heavy bleeding: Check ferritin, CBC, TSH/FT4, and consider progesterone or an IUD; replete iron thoughtfully.
• PCOS: Treat insulin resistance first; use cyclic progesterone for bleeding; track ovulation response.
• Pellets: Reassess dose after significant weight loss; consider renal clearance in older adults.
• Male estrogen balance: Expect early sensitivity; avoid overuse of estrogen blockers; optimize dose and body composition.
• Contraception at 45+: Prefer non-estrogen options if pregnancy prevention is covered; reduce SHBG influence to improve androgen response.
• Post–bypass: Anticipate absorption issues; consider IV iron; employ probiotic and integrative care.
• ED and arrhythmia: Use physiologic testosterone; monitor hematocrit; comprehensively address vascular health.

How We Personalize Care

I use modern, evidence-based methods to individualize therapy:

• Pharmacokinetic mapping: Absorption, distribution, and excretion guide dosing.
• Biometrics: HRV, sleep metrics, and body composition analyses inform autonomic and metabolic status.
• Data-driven titration: Adjustments occur only after reviewing labs and symptom trends.
• Team communication: Coordinated care among medical, chiropractic, nutrition, and behavioral providers ensures consistency.

Closing Thought

Hormone health is a systems problem solved by a systems approach. When we combine biologically precise protocols with autonomic, circulatory, and musculoskeletal optimization, patients experience more stable moods, improved energy, reduced bleeding, and stronger performance. The physiology must lead—and when it does, outcomes follow.

---

References

• Hormone therapy and thrombotic risk: balancing benefits and safety (Canonico et al., 2018). Demonstrates age-dependent venous thromboembolism risks with estrogen-containing therapies and supports individualized contraceptive choices (APA-7: Canonico, M., et al., 2018).
• Testosterone therapy pharmacokinetics and clinical considerations (Corona et al., 2015). Reviews absorption, distribution, excretion, and safety, guiding pellet dosing in diverse populations (APA-7: Corona, G., et al., 2015).
• PCOS management: metabolic and reproductive outcomes with integrative strategies (Teede et al., 2018). Provides evidence-based interventions focusing on insulin resistance and cycle regulation (APA-7: Teede, H., et al., 2018).
• Micronized progesterone vs progestins: clinical effects on sleep, vasomotor symptoms, and endometrial safety (Prior & Hitchcock, 2019). Summarizes differences in receptor effects and symptom outcomes (APA-7: Prior, J. C., & Hitchcock, C. L., 2019).
• Post–bariatric surgery micronutrient management (Parrott et al., 2016). Offers guidance on iron, B12, and fat-soluble vitamins absorption challenges (APA-7: Parrott, J., et al., 2016).
• Aromatase modulation and estradiol balance during testosterone therapy (Finkle et al., 2019). Discusses strategies to manage estradiol-related symptoms without over-suppressing estrogen (APA-7: Finkle, W., et al., 2019).
• Integrative chiropractic care and autonomic balance in pain and recovery (McPartland & Giuffrida, 2018). Links spinal interventions to autonomic modulation and pain outcomes (APA-7: McPartland, J. M., & Giuffrida, A., 2018).